Recalls & Warnings May 01, 2023 TruVision Recalls Products Due to Presence of Potentially Dangerous Ingredients On April 27, 2023, TruVision Health issued a recall of various dietary supplement products because they contain hordenine and/or octodrine/DMHA, compounds that the FDA considers to be possibly unsafe and which are not permitted to be sold as dietary supplements
This kind of approach akin to an antibiotic but ultra-narrow in spectrum could be used for other microbial pathways too
Intravenous (IV) Therapy remains a critical segment in the medical field, while Sports Nutrition sees growth due to its potential for reducing muscle fatigue and improving recovery
The area around the belly button has different tissue composition and blood flow, which can affect absorption and increase bruising risk
Repurposing Sigma-1 receptor ligands for COVID-19 therapy
Lin D, Tucker MJ, Rieder MJ